Basit öğe kaydını göster

Aggressive Clinicopathological Course Of Myeloma With T(3;16) (Q21;Q22) Cytogenetic Abnormality

dc.contributor.authorBozkurt, Süreyya
dc.contributor.authorOkay, Müfide
dc.contributor.authorHaznedaroğlu, İbrahim
dc.date.accessioned2021-06-03T05:20:04Z
dc.date.available2021-06-03T05:20:04Z
dc.date.issued2019
dc.identifier.issn1300-7777
dc.identifier.urihttp://dx.doi.org/10.4274/tjh.galenos.2018.2018.0049
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373501/
dc.identifier.urihttp://hdl.handle.net/11655/23977
dc.language.isoen
dc.relation.isversionof10.4274/tjh.galenos.2018.2018.0049
dc.rightsAttribution 4.0 United States
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleAggressive Clinicopathological Course Of Myeloma With T(3;16) (Q21;Q22) Cytogenetic Abnormality
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalTurkish Journal Of Hematology
dc.contributor.departmentİç Hastalıkları
dc.identifier.volume36
dc.identifier.issue1
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Ad:
scd28.pdf
Boyut:
556.5Kb
Biçim:
PDF
Göster/Aç

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

Attribution 4.0 United States
Aksi belirtilmediği sürece bu öğenin lisansı: Attribution 4.0 United States